Hologic’s HOLX acquisition of Biotheranostics in 2021 accelerated its entry into a large, fast-growing oncology adjacency. The business also carries higher margins than the company’s legacy service ...
The FDA has granted Cleveland Diagnostics’ IsoPSA test premarket approval (PMA) to help detect prostate cancer in men aged 50 years or older with elevated PSA levels. IsoPSA is a blood assay that ...
CLEVELAND--(BUSINESS WIRE)--Cleveland Diagnostics, Inc., a pioneering, commercial-stage precision oncology company, announced today that the U.S. Food and Drug Administration (FDA) has approved the ...
The Pakistan Navy on Tuesday conducted a successful test of an indigenously developed ship-launched anti-ship ballistic missile, according to the military’s media affairs wing. According to the ...
The FDA approved Cleveland Diagnostics' blood-based test to help diagnose high-grade prostate tumors and aid in biopsy decisions, the company announced. Dubbed IsoPSA, the in vitro diagnostic kit is ...
AI chatbots have been linked to serious mental health harms in heavy users, but there have been few standards for measuring whether they safeguard human well-being or just maximize for engagement. A ...
Pakistan Navy has successfully carried out a test flight of an indigenously developed ship-launched anti-ship ballistic missile, the military’s media wing said on Tuesday. According to ISPR, the ...
Abbott Laboratories is acquiring Exact Sciences, in a move that will help bolster its diagnostics business. Abbott should expand the reach of Exact Sciences' key products and fuel its innovative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results